Single and multiple investigation activity potential luteolin against Candida albicans, Escherichia coli and Pseudomonas aeruginosa
Archives of Microbiology · 2026-09 · 208 (9)
DOI: 10.1007/s00203-026-04985-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Microbiology, online erschienen am 16.06.2026. Verfasst von Demet Celebi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Veterinary Medicine, Department of Microbiology, Atatürk University, 25240, Erzurum, Turkey. celebiidil@atauni.edu.tr. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Candida albicans, Luteolin, Escherichia coli. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Ataturk University Scientific Research Coordination Office.
Abstract (Originalsprache)
Candida albicans is an opportunistic pathogen that can cause invasive infections, especially under conditions of immunosuppression and dysbiosis. Its presence alongside Pseudomonas aeruginosa and Escherichia coli may lead to polymicrobial biofilm-related infections. Due to rising antimicrobial resistance, alternative therapies are being explored, including luteolin, a natural flavonoid with reported in vitro antimicrobial activity. This study evaluated the in vitro antimicrobial and antibiofilm effects of luteolin against C. albicans, E. coli, and P. aeruginosa, both individually and in combination. Methods involved determining minimum inhibitory concentrations, using scanning electron microscopy, fibroblast viability tests, ELISA-based cytokine measurements, and RT-qPCR analysis of key biofilm- and quorum-sensing-related genes (luxS, lasI, and ALS1). MIC values were 0.011 mg/mL for individual strains and 0.046 mg/mL for the polymicrobial mixture. Luteolin treatment reduced microbial adherence and improved fibroblast viability compared to infected controls. Infection increased IL-1β levels and decreased IL-10 levels, effects that luteolin partially reversed. RT-qPCR showed downregulation of selected biofilm-related genes at 2×MIC. These findings demonstrate luteolin's measurable antimicrobial and anti-biofilm effects in vitro under controlled laboratory conditions, supporting further validation in preclinical models to assess translational potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Veterinary Medicine, Department of Microbiology, Atatürk University, 25240, Erzurum, Turkey. celebiidil@atauni.edu.tr.
- Vaccine Development Application and Research Center, Atatürk University, 25240, Erzurum, Turkey. celebiidil@atauni.edu.tr.
- Faculty of Medicine, Department of Medical Microbiology, Atatürk University, 25240, Erzurum, Turkey.
- Faculty of Pharmacy, Department of Pharmaceutical Microbiology, Erzincan Binali Yıldırım University, 24002, Erzincan, Turkey.
- Faculty of Medicine, Department of Physiology, Atatürk University, 25240, Erzurum, Turkey.
- Department of Medical Pharmacology, Faculty of Medicine, Bilecik Şeyh Edebali University, 11230, Bilecik, Turkey.
Förderung
- Ataturk University Scientific Research Coordination Office
Zitieren
APA
Celebi, D., Celebi, O., Baser, S., Guler, M. C., Taghizadehghalehjoughi, A., Aydin, E., Genc, S., & Hacimuftuoglu, A. (2026). Single and multiple investigation activity potential luteolin against Candida albicans, Escherichia coli and Pseudomonas aeruginosa. Archives of Microbiology, 208(9). https://doi.org/10.1007/s00203-026-04985-5
Vancouver
Celebi D, Celebi O, Baser S, Guler MC, Taghizadehghalehjoughi A, Aydin E, et al. Single and multiple investigation activity potential luteolin against Candida albicans, Escherichia coli and Pseudomonas aeruginosa. Archives of Microbiology. 2026;208(9). doi:10.1007/s00203-026-04985-5
BibTeX
@article{Celebi2026,
author = {Celebi, Demet and Celebi, Ozgur and Baser, Sumeyye and Guler, Mustafa Can and Taghizadehghalehjoughi, Ali and Aydin, Elif and Genc, Sidika and Hacimuftuoglu, Ahmet},
title = {Single and multiple investigation activity potential luteolin against Candida albicans, Escherichia coli and Pseudomonas aeruginosa},
journal = {Archives of Microbiology},
year = {2026},
volume = {208},
number = {9},
doi = {10.1007/s00203-026-04985-5}
}
EUVIMED